Citation Impact
Citing Papers
Characterization of a canine homolog of hepatitis C virus
2011 StandoutNobel
Rapid detection of Mycobacterium tuberculosis in sputum with a solvatochromic trehalose probe
2018 StandoutNobel
Origin of Antibiotics and Antibiotic Resistance, and Their Impacts on Drug Development: A Narrative Review
2023 Standout
Challenges in the Treatment of Chronic Wounds
2015 Standout
Phenotypic and genotypic characteristics of carbapenem-resistant Enterobacteriaceae in a tertiary-level reference hospital in Turkey
2016
Leptospirosis presenting to an intensive care unit in provincial New Zealand: a case series and review
2006
Leptospirosis in Humans
2014 Standout
Liver fibrosis
2005 Standout
Diabetic Foot Ulcers and Their Recurrence
2017 Standout
Leptospirosis
2005 Standout
From the discovery of the Malta fever?s agent to the discovery of a marine mammal reservoir, brucellosis has continuously been a re-emerging zoonosis
2005 Standout
Ofloxacin plus Rifampicin versus Doxycycline plus Rifampicin in the treatment of brucellosis: a randomized clinical trial [ISRCTN11871179]
2004
Transmission of hepatitis C virus by saliva?
2005
In diabetic foot infections antibiotics are to treat infection, not to heal wounds
2015
Is Sexual Contact a Major Mode of Hepatitis C Virus Transmission?
2010
Epidemiological features and clinical manifestations in 469 adult patients with brucellosis in Babol, Northern Iran
2004
Absence of hepatitis C virus transmission in a prospective cohort of heterosexual serodiscordant couples
2003
The new global map of human brucellosis
2006 Standout
Brucellosis
2005 Standout
Epidemiology and Outcome of Zygomycosis: A Review of 929 Reported Cases
2005 Standout
Impact of clinical and laboratory findings on prognosis in leptospirosis
2004
Emerging Issues in Gram-Negative Bacterial Resistance
2015
Maternal and neonatal tetanus
2007
Acute brucellosis: presentation, diagnosis, and treatment of 144 cases
2006
Brucellosis: A re-emerging zoonosis
2009 Standout
Human brucellosis in a nonendemic country: a report from Germany, 2002 and 2003
2005
Doxycycline plus streptomycin versus ciprofloxacin plus rifampicin in spinal brucellosis [ISRCTN31053647]
2006
Carbapenem-Resistant Enterobacteriaceae Infections in Children
2015
Global, regional, and national causes of child mortality: an updated systematic analysis for 2010 with time trends since 2000
2012 Standout
Risk factors of hepatitis C virus‐related liver cirrhosis in young adults: Positive family history of liver disease and transporter associated with antigen processing 2 (TAP2) *0201 Allele
2001
Biological weapons
2006
Neurological and systemic complications of tuberculous meningitis and its treatment at Auckland City Hospital, New Zealand
2010
Clinical manifestations and complications in 1028 cases of brucellosis: a retrospective evaluation and review of the literature
2009 Standout
Scintigraphic findings in osteoarticular brucellosis
2005
β-Lactams and β-Lactamase Inhibitors: An Overview
2016 Standout
Diagnostics and treatment of the diabetic foot
2012
Human brucellosis
2007 Standout
Comparison between doxycycline–rifampin–amikacin and doxycycline–rifampin regimens in the treatment of brucellosis
2006
Antimicrobial strategies centered around reactive oxygen species – bactericidal antibiotics, photodynamic therapy, and beyond
2013 Standout
Hip arthritis in brucellosis: a study of 33 cases in the Republic of Macedonia (FYROM)
2004
Incidence and control of brucellosis in the Near East region
2002
Treatment of brucella spondylitis: lessons from an impossible meta-analysis and initial report of efficacy of a fluoroquinolone-containing regimen
2004
Dexamethasone for treatment of tuberculous meningitis in adolescents and adults
2005
Posaconazole vs. Fluconazole or Itraconazole Prophylaxis in Patients with Neutropenia
2007 Standout
2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association
2021 Standout
Update on management of diabetic foot ulcers
2018 Standout
Effective treatments in the management of brucellosis
2005
Sexually Transmitted Infections Treatment Guidelines, 2021
2021 Standout
A systematic review of the effectiveness of interventions in the management of infection in the diabetic foot
2012
Laboratory Diagnosis of Tuberculosis in Resource-Poor Countries: Challenges and Opportunities
2011
2016 Infectious Diseases Society of America (IDSA) Clinical Practice Guideline for the Treatment of Coccidioidomycosis
2016 Standout
WHS guidelines update: Diabetic foot ulcer treatment guidelines
2015
Correlation between the Antibiotic Resistance Genes and Susceptibility to Antibiotics among the Carbapenem-Resistant Gram-Negative Pathogens
2021
Sexually Transmitted Diseases Treatment Guidelines, 2010
2011 Standout
Global epidemiology of diabetic foot ulceration: a systematic review and meta-analysis
2016 Standout
Klebsiella pneumoniae: Going on the Offense with a Strong Defense
2016 Standout
Prospective Evaluation of 140 Patients With Brucellosis in the Southern Region of Turkey
2007
Research confuses me: what is the difference between case-control and cohort studies in quantitative research?
2013 Standout
Antibacterial activity of Tribulus terrestris methanol extract against clinical isolates of Escherichia coli
2016
Bacterial Antibiotic Resistance: The Most Critical Pathogens
2021 Standout
Practical Guidelines on the prevention and management of diabetic foot disease (IWGDF 2019 update)
2020 Standout
Antioxidant, Antimicrobial and Antiviral Properties of Herbal Materials
2020 Standout
Human brucellosis: an overview
2003
2012 Infectious Diseases Society of America Clinical Practice Guideline for the Diagnosis and Treatment of Diabetic Foot Infectionsa
2012 Standout
Carbapenemase-Producing Klebsiella pneumoniae, a Key Pathogen Set for Global Nosocomial Dominance
2015
Epidemiology of antimicrobial resistance in bloodstream infections
2016
The Epidemiology of Carbapenem-Resistant Enterobacteriaceae: The Impact and Evolution of a Global Menace
2017 Standout
The global epidemiology of carbapenemase-producing Enterobacteriaceae
2016 Standout
Antimicrobial Resistance in ESKAPE Pathogens
2020 Standout
In Vitro Spectrum of Pexiganan Activity When Tested against Pathogens from Diabetic Foot Infections and with Selected Resistance Mechanisms
2015
Guidelines on the diagnosis and treatment of foot infection in persons with diabetes (IWGDF 2019 update)
2020
Quinolones for Treatment of Human Brucellosis: Critical Review of the Evidence from Microbiological and Clinical Studies
2005
Works of Neşe Saltoğlu being referenced
Fever of unknown origin in Turkey: evaluation of 87 cases during a nine-year-period of study
2003
Osteoarthricular Involvement of Brucellosis in Turkey
1999
Prognostic factors affecting deaths from adult tetanus
2004
Blood stream infections due to OXA-48-like carbapenemase-producing Enterobacteriaceae: treatment and survival
2014
Sexual and non-sexual intrafamilial spread of hepatitis C virus: Intrafamilial transmission of HCV
1998
Rhinocerebral zygomycosis treated with liposomal amphotericin B and surgery
1998
Tuberculous meningits in adults in Turkey: Epidemiology, diagnosis, clinic and laboratory
2003
Piperacillin/tazobactam versus imipenem/cilastatin for severe diabetic foot infections: a prospective, randomized clinical trial in a university hospital
2009
Comparison of community-onset healthcare-associated and hospital-acquired urinary infections caused by extended-spectrum beta-lactamase-producingEscherichia coliand antimicrobial activities
2015
Predictors of outcome in patients with tuberculous meningitis.
2002
Leptospirosis: twelve Turkish patients with the Weil syndrome.
1997
Association between biofilm and multi/extensive drug resistance in diabetic foot infection
2018
Efficacy of rifampicin plus doxycycline versus rifampicin plus quinolone in the treatment of brucellosis.
2002
Improved Sensitivity of Nucleic Acid Amplification for Rapid Diagnosis of Tuberculous Meningitis
2004